Interpretation and implementation of adult diagnostic reference levels in nuclear medicine and PET in the UK

Louise Fraser*, Nasreen Parkar, Amina Powell, Mark Richardson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

In the UK, the Administration of Radioactive Substances Advisory Committee (ARSAC) sets and publishes National Diagnostic Reference Levels (NDRLs) for diagnostic nuclear medicine (NM) and Positron Emission Tomography procedures. This article summarises how these NDRLs should be applied and used within the UK and proposes a new model on how they are set. As an exemplar, the results of a recent survey of administered activities in the UK for 18F-fluorodeoxyglucose (FDG) for whole-body tumour imaging and infection inflammation imaging are presented here. ARSAC recommends that the UK NDRLs for NM or PET examinations are set as either a fixed activity (MBq) or by administered activity per body weight (MBq/ kg). ARSAC proposes setting the first weight-based activity scaling NDRLs for 18F-FDG whole-body tumour imaging and 18F-FDG infection inflammation imaging to 3.5 MBq/ kg.

Original languageEnglish
Pages (from-to)379-383
Number of pages5
JournalNuclear Medicine Communications
Volume46
Issue number5
DOIs
Publication statusPublished - 5 Feb 2025

Bibliographical note

Publisher Copyright:
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

Keywords

  • PET
  • administered activity
  • diagnostic reference levels
  • nuclear medicine
  • optimisation

Fingerprint

Dive into the research topics of 'Interpretation and implementation of adult diagnostic reference levels in nuclear medicine and PET in the UK'. Together they form a unique fingerprint.

Cite this